Stay updated on Xospata Safety in Relapsed AML Clinical Trial

Sign up to get notified when there's something new on the Xospata Safety in Relapsed AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Xospata Safety in Relapsed AML Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    ClinicalTrials.gov’s interface revision indicator was updated from v3.5.2 to v3.5.3, reflecting a platform/version change rather than a modification to the trial record itself.
    Difference
    0.1%
    Check dated 2026-04-24T05:50:34.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and removed Revision: v3.5.0 from the study record history.
    Difference
    0.1%
    Check dated 2026-04-17T02:28:45.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    45 days ago
    Change Detected
    Summary
    Revision v3.5.0 was added to the Record History. Revision v3.4.3 was removed from the Record History.
    Difference
    0.1%
    Check dated 2026-03-19T04:53:33.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Added revision entry v3.4.3 and removed v3.4.2 from the record history.
    Difference
    0.1%
    Check dated 2026-03-12T00:01:27.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    A new site revision note, Revision: v3.4.2, was added, and the government-funding notice along with the previous Revision: v3.4.1 entry were removed.
    Difference
    0.5%
    Check dated 2026-02-11T12:37:47.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    A site-wide notice about potential delays due to a lapse in government funding was added, and the release version was updated from v3.4.0 to v3.4.1.
    Difference
    0.5%
    Check dated 2026-02-04T06:54:49.000Z thumbnail image

Stay in the know with updates to Xospata Safety in Relapsed AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Xospata Safety in Relapsed AML Clinical Trial page.